Back to Metaplastic Breast Cancer

 

References for Metaplastic Breast Cancer

 

• Anders C.  (2008)  Understanding and Treating Triple-Negative Breast Cancer. Oncology, Vol. 22 No. 11  https://www.ncbi.nlm.nih.gov/pubmed/18980022
• Dave G, Cosmatos H, Do T, Lodin K, Varshney D.  (2006) Metaplastic carcinoma of the breast: A retrospective review
  International Journal of Radiation OncologyBiologyPhysics, Volume 64, Issue 3, Pages 771-775  https://www.ncbi.nlm.nih.gov/pubmed/16246496
• Dent R, Trudeau M, Pritchard KI, Hanna WM. (et al). (2007)  Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 13:4429-4434, 2007.  https://www.ncbi.nlm.nih.gov/pubmed/17671126
• Esses, K, Hagmaier R, Blanchard S, Lazarchick, J, Riker A. (2009) Carcinosarcoma of the breast: two case reports and review of the literature. Cases Journal 2009, 2:15  https://www.ncbi.nlm.nih.gov/pubmed/19126225
• Feder JM, de Paredes ES, Hogge JP, Wilken JJ. (1999) Unusual breast lesions: radiologic—pathologic correlation. RadioGraphics 1999;19[suppl]:S11 -S26  http://pubs.rsna.org/doi/full/10.1148/radiographics.19.suppl_1.g99oc07s11
• Foschini MP, Dina RE, Eusebi V. (1993) Sarcomatoid neoplasms of the breast: Proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol 1993 , 10(2):128-136.  https://www.ncbi.nlm.nih.gov/pubmed/8367622
• Gunhan-Bilgen I, Memis A, Ustun EE, Zekiogl O, Oxdemir N. (2002) Metaplastic Carcinoma of the Breast: Clinical, Mammographic, and Sonographic Findings with Histopathologic Correlation .AJR 2002; 178:1421-1425  https://www.ncbi.nlm.nih.gov/pubmed/12034610
• Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz , Babiera G, Hortobagyi GN, Valero V. (2006)  Biphasic metaplastic sarcomatoid carcinoma of the breast. Annals of Oncology 2006 , 17:605-613.  https://academic.oup.com/annonc/article/17/4/605/247730
• Leibl S, Moinfar F. (2005) Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol 2005;58:700-704  https://www.ncbi.nlm.nih.gov/pubmed/15976335
• Lim KH, Oh DY, Chie EK, Han W, Im SA, Kim TY. (et al).  Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity. Japanese Journal of Clinical Oncology 2010 40(2):112-118 https://www.ncbi.nlm.nih.gov/pubmed/19887523
• Patterson SK, Tworek JA, Roubidoux MA, Helvie MA, Oberman HA.  (1997) Metaplastic carcinoma of the breast: mammographic appearance with pathologic correlation. AJR 1997;169:709 -712  https://www.ncbi.nlm.nih.gov/pubmed/9275883
• Reis-Filho J, Milanezi F, Steele D.  (et al). (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology 49:10-21, 2006.    https://www.ncbi.nlm.nih.gov/pubmed/16842242
• Tokudome N, Sakamoto G, Sakai T, Sarumaru S, Okuyama N, Hori F. (2005)  A case of carcinosarcoma of the breast. Breast Cancer 2005 , 12(2):149-153.  https://www.ncbi.nlm.nih.gov/pubmed/15858448

Back to Metaplastic Breast Cancer